Artivion (AORT) vs SI-BONE (SIBN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
SI-BONE (SIBN) has outperformed Artivion (AORT) over the past year, gaining 24.6% versus a loss of 46.7%. Over five years, AORT leads with a +1.2% price change compared with -16.4% for SIBN. Artivion is the larger company by market cap ($1.03 billion vs $845.3 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AORT | SIBN |
|---|---|---|
| Share price | $21.21 | $18.86 |
| Market cap | $1.03B | $845.28M |
| 1-day change | -1.85% | -1.26% |
| YTD return | -52.62% | -3.14% |
| 1-year return | -46.66% | +24.59% |
| 5-year return | +1.17% | -16.41% |
| Forward P/E | 28.34 | — |
| EPS (TTM) | $-0.07 | $-0.34 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $48.25 | $21.89 |
| 52-week low | $19.16 | $11.48 |
| Distance from 52-week high | -56.04% | -13.84% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +98.73% | +33.72% |
| Average volume | 634.11K | 541.14K |
| Shares outstanding | 48.76M | 44.82M |
| Employees | 1,800 | 376 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SIBN has outperformed AORT by 71.2 percentage points over the past year.
About Artivion
AORT stock →Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide.
Health Care · Medical/Dental Instruments · 1,800 employees
About SI-BONE
SIBN stock →SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products.
Health Care · Medical/Dental Instruments · 376 employees
AORT vs SIBN FAQ
Which is bigger, Artivion or SI-BONE?
Artivion (AORT) is larger, with a market capitalization of $1.03B compared with $845.28M for SI-BONE (SIBN).
Which stock has performed better over the past year, AORT or SIBN?
SIBN returned +24.59% over the past 12 months, compared with -46.66% for AORT (price return, excluding dividends). Past performance does not predict future results.
Are Artivion and SI-BONE in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.